Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lisata Therapeutics (LSTA) Debt Ratio (2016 - 2017)

Lisata Therapeutics filings provide 8 years of Debt Ratio readings, the most recent being 0.01 for Q2 2017.

  • For the quarter ending Q2 2017, Debt Ratio fell 95.79% year-over-year to 0.01, compared with a TTM value of 0.01 through Jun 2017, down 95.79%, and an annual FY2016 reading of 0.08, down 5.42% over the prior year.
  • Debt Ratio hit 0.01 in Q2 2017 for Lisata Therapeutics, down from 0.07 in the prior quarter.
  • The five-year high for Debt Ratio was 0.16 in Q2 2016, with the low at 0.01 in Q4 2013.
  • Median Debt Ratio over the past 5 years was 0.07 (2017), compared with a mean of 0.07.
  • The sharpest move saw Debt Ratio surged 1908.62% in 2014, then crashed 95.79% in 2017.
  • Year by year, Debt Ratio stood at 0.01 in 2013, then skyrocketed by 1908.62% to 0.12 in 2014, then crashed by 30.03% to 0.08 in 2015, then decreased by 5.42% to 0.08 in 2016, then plummeted by 91.66% to 0.01 in 2017.
  • According to Business Quant data, Debt Ratio over the past three periods came in at 0.01, 0.07, and 0.08 for Q2 2017, Q1 2017, and Q4 2016 respectively.